Shell Asset Management CO Amphastar Pharmaceuticals, Inc. Transaction History
Shell Asset Management CO
- $2.27 Billion
- Q3 2024
A detailed history of Shell Asset Management CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 4,850 shares of AMPH stock, worth $175,279. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,850
Previous 5,128
5.42%
Holding current value
$175,279
Previous $205,000
14.63%
% of portfolio
0.01%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding AMPH
# of Institutions
280Shares Held
36MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$215 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$98 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$77.2 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$70.4 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$58.4 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.77B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...